• Antitrust/Competition
  • Clear
  • Most Recent
  • Most Relevant
381 results
Alert
JFTC Report: Competition policy and antitrust law perspective on the initial public offering (IPO) pricing process
Alert
European Commission issues proposed guidance on information exchange in dual distribution relationships
Alert
China Issued New Measures for Cybersecurity Review in 2022
Alert
UK Government publishes illustrative guidance on the future operation of its subsidy control regime
Alert
Italy Transposes the ECN+ Directive: Significant New Powers for the Italian Competition Authority
Record breaker: US M&A 2021
Insight
Antitrust: Extended timelines and broader scope
The Federal Trade Commission is taking an increasingly stringent approach to antitrust investigations
Alert
Drug Pricing Issues to Watch in 2022
Alert
EU General Court demands a vigorous effects-based analysis for rebates cases and annuls the European Commission’s Intel decision and the €1.06 billion fine
Alert
FTC Announces Annual Changes to HSR Thresholds (2022)
Alert
New Capitalism in Japan: Measures to Facilitate Pass-on for Value Creation through Partnerships, including by the JFTC
Alert
Four key antitrust events in Q4 2021 target labor markets and aim to protect workers: Here's what you need to know
LIghthouse
Insight
Shining a light on the massive global surge in merger control filings
The data White & Case gathered from 58 of the most active merger control jurisdictions globally reveals trends and insights that can't be gleaned from data on single jurisdictions considered in isolation.
Alert
JFTC and METI Proposes Guidelines for Business Collaboration with Startups and Investment in Startups
Alert
German and Austrian competition authorities publish updated joint guidance on transaction value thresholds
Alert
New Capitalism in the Kishida Administration and Competition Policy in Japan
Alert
Key Developments in Saudi Arabia Merger Control: First Rejection, Review Guidelines, and New Tools
Article
Lexology GTDT: EU Antitrust Developments in the Pharmaceutical Sector
Article
Law360 Expert Analysis: Questions To Ask If Doing Business In A Corruption Hot Spot
Alert
Everybody Needs Prior Approval! – The FTC Revives And Expands an Old Enforcement Tool over a Scathing Dissent
Alert
No-poach agreements on the European Commission dawn raid radar
Alert
The Italian Government Approves the Draft Annual Law for Competition (ddl Concorrenza)
Newsletter
Overview of global antitrust and merger regimes
Interactive guides to competition law enforcement and merger control activity in the South America and Southeast Asia and Pacific regions
Article
United States: Pharmaceutical Antitrust 2022
Alert
UK clampdown on greenwashing
Taiwanese investors and businesses: Forging a path through global transitions
Insight
Taiwanese investors and businesses: Forging a path through global transitions
Key legal developments in 2021 and their implications for Taiwan
desktop source code
Insight
US antitrust policy targets the technology sector
Taiwanese companies could feel the impact of the current push for wide-scale change
circuit board
Insight
Europe takes a tougher approach to technology mergers
Taiwanese companies should keep Europe in mind when planning new deals
Alert
HHS Report Reiterates Biden Administration Support for Wide-Ranging Action to Address Drug Prices
Alert
Autumn dawn raid revival on the cards for European competition authorities
race track
Video
The Supreme Court's NCAA Decision and Its Implications for Antitrust Law
Alert
States Remain the Drivers of New Drug Pricing Legislation As Washington Weighs In
Article
Third Circuit: Pharmaceutical Cases
Alert
Federal Trade Commission’s Pre-Consummation Warning Letters Signal New Risk of Closing After Hart-Scott-Rodino Act Waiting Period Expiration
Alert
Technology Industry Should Watch Closely as the Executive Branch and Lawmakers Set Their Sights on Antitrust
Alert
UK National Security and Investment Act screening regime to go live from 4 January 2022
Alert
Analysis: FTC Encouraged to Ban or Limit Non-Compete Agreements in July 9, 2021 Executive Order; Breaks With Tradition, And Follows Trend of Heightened Antitrust Focus on Labor Markets
Alert
New EU competition rules for distribution agreements
Alert
What Does President Biden’s July 9, 2021 Executive Order on Competition Mean for the Pharma Industry?
World in transition
Insight
Sweeping US Order on “Promoting Competition”
The new Executive Order includes 72 initiatives instructing more than a dozen federal agencies to consider adopting rules intended to enhance competition. 
Alert
House Bill Mandating User Data Portability and Platform Interoperability Could Impact Digital Companies of All Sizes